| Date Filed | Type | Description |
| 01/24/2023 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 33.5% stake in Minerva Surgical, Inc. |
| 11/04/2022 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for PhaseBio Pharmaceuticals, Inc. |
| 02/07/2022 |
SC 13G
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 11.3% stake in * Coursera, Inc. |
| 02/07/2022 |
SC 13G/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Cloudflare, Inc. |
| 01/13/2022 |
SC 13D
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 13.8% stake in BuzzFeed, Inc. |
| 11/17/2021 |
SC 13D
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 35% stake in Minerva Surgical, Inc. |
| 02/24/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/06/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Ra Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 18.8% stake in Sprout Social, Inc. |
| 02/13/2020 |
SC 13G
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 39.7% stake in Cloudflare, Inc. |
| 01/14/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 6.4% stake in Dermira, Inc. |
| 10/17/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 13% stake in Ra Pharmaceuticals, Inc. |
| 07/08/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Epizyme, Inc. |
| 01/30/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for TESARO, Inc. |
| 12/06/2018 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 19% stake in TESARO, Inc. |
| 10/31/2018 |
SC 13D
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 27.9% stake in PhaseBio Pharmaceuticals, Inc. |
| 03/09/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/27/2018 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 17.7% stake in Ra Pharmaceuticals, Inc. |
| 01/10/2018 |
SC 13G/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Aerohive Networks, Inc. |
| 01/10/2018 |
SC 13G/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Care.com, Inc. |
| 10/13/2017 |
SC 13D
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 18.8% stake in Rhythm Pharmaceuticals, Inc. |
| 02/06/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 11/04/2016 |
SC 13D
| Ra Pharmaceuticals, Inc. reports a 16.2% stake in Ra Pharmaceuticals, Inc. |
| 09/28/2016 |
SC 13D/A
| Roka BioScience, Inc. reports a 37.9% stake in Roka Bioscience, Inc. |
| 03/28/2016 |
SC 13D/A
| TESARO, Inc. reports a 25.6% stake in TESARO, Inc. |
| 03/25/2016 |
SC 13G/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 9.8% stake in Aerohive Networks, Inc. |
| 02/05/2016 |
SC 13G/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 9.8% stake in Aerohive Networks, Inc. |
| 04/23/2013 |
SC 13D
| Omthera Pharmaceuticals, Inc. reports a 23.9% stake in Omthera Pharmaceuticals, Inc. |
| 07/10/2012 |
SC 13D
| Tesaro, Inc. reports a 43.1% stake in TESARO, Inc. |
| 11/28/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |